1-Linoleoyl Lysophosphatidic Acid sodium

1-Linoleoyl lysophosphatidic acid is a selective LPA2 receptor agonist (EC50 ~10 nM) and the major LPA species in plasma. Its levels are altered in disease states, being elevated in murine tumor models and decreased in primary progressive multiple sclerosis, where it correlates inversely with neurological deficit severity. This compound is a valuable tool for researching LPA receptor signaling in cancer and neuroinflammatory contexts.